Not FDA-approved · the FDA's words and sellers' current prices

Is compounded semaglutide legal?

Last updated

Prices checked through Nov 17, 2026 · FDA page read Nov 4, 2026

Compounded semaglutide: the lowest prices now, not FDA-approved

  • Lowest compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Compounded semaglutide is still made and sold in the US, under limits the FDA has set: 462 US sellers publish a current price for it, the lowest on a monthly plan $59/mo + $199/yr membership (about $76 a month over a year with the membership) at Collective, read on their own pages (November 2026). The FDA declared the semaglutide shortage resolved in February 2025, which ended the exemption that let pharmacies make copies in bulk. Its statement of Apr 1, 2026 sets the conditions, among them: "The drug product is compounded for an individual patient based on receipt of a prescription." No ban has been announced that we have read. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. Whether one prescription fits those limits is for the prescriber and the pharmacy to decide. FDA, Apr 1, 2026 (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) (FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize) FDA on the shortages (fda.gov) (FDA: policies for compounders as the GLP-1 supply stabilizes)

Questions

Compounded semaglutide and the law

Is compounded semaglutide legal?

It is still made and sold under limits. The FDA declared the shortage resolved in February 2025, which ended the exemption that let pharmacies make copies of the approved drug in bulk. In its statement of Apr 1, 2026, the conditions include: "The drug product is compounded for an individual patient based on receipt of a prescription", and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." It adds: "This is unless a prescriber determines and documents the compounded drug product contains a change that produces a significant difference from the commercially available drug product for an identified individual patient." It also says: "Tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list." Whether one prescription fits those limits is for the prescriber and the pharmacy to decide. FDA's statement of Apr 1, 2026

Can you still get compounded semaglutide?

Yes: 462 US sellers publish a current price for it, the lowest on a monthly plan $59/mo + $199/yr membership (about $76 a month over a year with the membership) at Collective. A prescriber and a pharmacy decide whether a given prescription fits the limits on compounding. Every compounded semaglutide price, lowest first

Is compounded semaglutide legal in California?

California has a rule of its own: the California Board of Pharmacy compounding regulations, in effect since Oct 1, 2025, say: “‘Essentially a copy’ of a commercially available drug product means a preparation that includes the same active pharmaceutical ingredient(s) (API(s)) as the commercially available drug product, except that it does not include any preparation in which there has been a change made for an identified individual patient that produces for that patient a clinically significant difference, as verified and documented by the pharmacist, between that compounded preparation and the comparable commercially available drug product.” Tirzepatide and semaglutide are sold as FDA-approved products, so under this rule a compounded version is “essentially a copy” unless the pharmacist documents a clinically significant difference for you as the patient, or the drug is on a shortage list. Ask the seller how its pharmacy meets California’s rule before you pay. AB 1990, a bill on compounded GLP-1 medicines for weight loss: Its last action, on August 13, 2026, left it in the Senate Appropriations Committee, so it has not become law. The FDA's conditions are federal and apply in every state. Its statement of April 1, 2026 includes: "The drug product is compounded for an individual patient based on receipt of a prescription", and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." The compounders' court challenge to FDA's semaglutide shortage decision failed: the US Court of Appeals for the Fifth Circuit wrote on Aug 27, 2026: "Any error by the FDA in not proceeding through the APA’s notice and comment procedures was harmless, and the FDA’s ultimate action was not arbitrary or capricious." (ca5.uscourts.gov/opinions/unpub/25/25-10758.0.pdf, read Nov 15, 2026.) On May 1, 2026 the Federal Register published FDA's proposal to leave semaglutide, tirzepatide and liraglutide off the 503B Bulks List, the ingredients outsourcing facilities may compound from (91 FR 23431, federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal); comments closed Jul 30, 2026, and no final notice was found when the Federal Register was last read (Nov 6, 2026). The California State Board of Pharmacy licenses pharmacies in California, and 256 sellers with a current price say they serve California. Whether one prescription fits those limits is for the prescriber and the pharmacy to decide. California's rules read Nov 14, 2026. Among sellers that say they serve California and state in days the supply the price buys, the lowest is Sunlight at ≈ $84 per 30 days (advertised as $78/mo, read Nov 11, 2026), then Strut Health at $99 per 30 days. Among sellers we link to that serve California, the lowest on a monthly plan is Mondae at $87 a month (advertised as $87/mo, read Nov 11, 2026). The lowest advertised figure is from $69/mo at Gala Health. It states no supply period, so it is not ranked per 30 days. Compounded products are not FDA-approved, so a lower price says nothing about quality. Compounded semaglutide in California: every seller that serves it

Is compounded semaglutide legal in Texas?

The FDA's conditions are federal and apply in every state. Its statement of April 1, 2026 includes: "The drug product is compounded for an individual patient based on receipt of a prescription", and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." The compounders' court challenge to FDA's semaglutide shortage decision failed: the US Court of Appeals for the Fifth Circuit wrote on Aug 27, 2026: "Any error by the FDA in not proceeding through the APA’s notice and comment procedures was harmless, and the FDA’s ultimate action was not arbitrary or capricious." (ca5.uscourts.gov/opinions/unpub/25/25-10758.0.pdf, read Nov 15, 2026.) On May 1, 2026 the Federal Register published FDA's proposal to leave semaglutide, tirzepatide and liraglutide off the 503B Bulks List, the ingredients outsourcing facilities may compound from (91 FR 23431, federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal); comments closed Jul 30, 2026, and no final notice was found when the Federal Register was last read (Nov 6, 2026). The Texas State Board of Pharmacy licenses pharmacies in Texas, and 278 sellers with a current price say they serve Texas. Whether one prescription fits those limits is for the prescriber and the pharmacy to decide. Among sellers that say they serve Texas, the lowest on a monthly plan is Collective at about $76 a month over a year with the membership (advertised as $59/mo + $199/yr membership, read Nov 15, 2026). Among sellers that say they serve Texas and state in days the supply the price buys, the lowest is Sunlight at ≈ $84 per 30 days (advertised as $78/mo, read Nov 11, 2026), then Strut Health at $99 per 30 days. Compounded products are not FDA-approved, so a lower price says nothing about quality. Compounded semaglutide in Texas: every seller that serves it

Is compounded semaglutide legal in Florida?

The FDA's conditions are federal and apply in every state. Its statement of April 1, 2026 includes: "The drug product is compounded for an individual patient based on receipt of a prescription", and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." The compounders' court challenge to FDA's semaglutide shortage decision failed: the US Court of Appeals for the Fifth Circuit wrote on Aug 27, 2026: "Any error by the FDA in not proceeding through the APA’s notice and comment procedures was harmless, and the FDA’s ultimate action was not arbitrary or capricious." (ca5.uscourts.gov/opinions/unpub/25/25-10758.0.pdf, read Nov 15, 2026.) On May 1, 2026 the Federal Register published FDA's proposal to leave semaglutide, tirzepatide and liraglutide off the 503B Bulks List, the ingredients outsourcing facilities may compound from (91 FR 23431, federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal); comments closed Jul 30, 2026, and no final notice was found when the Federal Register was last read (Nov 6, 2026). The Florida Board of Pharmacy licenses pharmacies in Florida, and 285 sellers with a current price say they serve Florida. Whether one prescription fits those limits is for the prescriber and the pharmacy to decide. Among sellers that say they serve Florida, the lowest on a monthly plan is Collective at about $76 a month over a year with the membership (advertised as $59/mo + $199/yr membership, read Nov 15, 2026). Among sellers that say they serve Florida and state in days the supply the price buys, the lowest is Sunlight at ≈ $84 per 30 days (advertised as $78/mo, read Nov 11, 2026), then Strut Health at $99 per 30 days. Compounded products are not FDA-approved, so a lower price says nothing about quality. Compounded semaglutide in Florida: every seller that serves it

Is compounded semaglutide going away?

No end date has been set that we have read. 462 US sellers still publish a price today. What is pending is narrower: in the Federal Register of May 1, 2026, FDA published "FDA's proposal not to include semaglutide, tirzepatide, or liraglutide on the 503B Bulks List", the list of ingredients that outsourcing facilities registered under section 503B may compound from; comments closed Jul 30, 2026, and we found no final notice when we last read the Federal Register (Nov 6, 2026). A pharmacy filling one patient's prescription works under the conditions quoted above. A seller can stop at any time, so check its page before you rely on a supply. The Federal Register notice of May 1, 2026

Did the FDA ban compounded semaglutide?

No ban has been issued. The shortage ended, and with it the exemption for making copies in bulk. The FDA has sent warning letters to pharmacies, and in its letter of Sep 18, 2026 to Empower Pharmacy it wrote: "The volume of products you are producing suggests that differences between products you are compounding and the FDA-approved products are pretextual." Every FDA statement and letter since the shortages ended

What happened in the compounded semaglutide lawsuit?

The compounders lost their appeal. In Outsourcing Facilities Association v. FDA (No. 25-10758), the US Court of Appeals for the Fifth Circuit, in its opinion filed Aug 27, 2026, wrote: "Any error by the FDA in not proceeding through the APA’s notice and comment procedures was harmless, and the FDA’s ultimate action was not arbitrary or capricious." The court marked it: "This opinion is not designated for publication. See 5th Cir. R. 47.5." (ca5.uscourts.gov/opinions/unpub/25/25-10758.0.pdf, read Nov 15, 2026.) The Fifth Circuit's opinion of Aug 27, 2026

Is compounded semaglutide with B12 still allowed?

Some sellers list it. The FDA's statement of Apr 1, 2026 says: "FDA may consider a compounded drug product that combines semaglutide API and another API, such as vitamin B12 (cyanocobalamin), to be essentially a copy of a commercially available drug product" when the route is the same and the strengths are within 10%. In its letter of Sep 18, 2026 to Empower Pharmacy, it wrote: "Specifically, your firm compounded products including TIRZEPATIDE/NIACINAMIDE (4 ML)(17/2 MG/ML), SEMAGLUTIDE/CYANOCOBALAMIN (1 ML)(5/0.5 MG/ML), and TIRZEPATIDE/NIACINAMIDE (2.5 ML)(8/2 MG/ML), which appear to be essentially copies of FDA-approved semaglutide and tirzepatide products."

Is compounded semaglutide FDA-approved?

No. Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. The FDA-approved semaglutide starts at $149 per 30 days without insurance, at the starting dose. FDA: concerns with unapproved GLP-1 drugs used for weight loss

The FDA's words

What the FDA said to compounders on Apr 1, 2026

  • “The drug product is compounded for an individual patient based on receipt of a prescription.”
  • “The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product.”
  • “This is unless a prescriber determines and documents the compounded drug product contains a change that produces a significant difference from the commercially available drug product for an identified individual patient.”
  • The FDA says “it does not intend to take action against a compounder for compounding a drug product that is essentially a copy of a commercially available drug product regularly or in inordinate amounts if the compounder fills four or fewer prescriptions of that compounded drug product during a calendar month.”
  • “Tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list.” FDA (fda.gov) (FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize)

Every FDA statement and warning letter since the shortages ended, for both medicines: can you still get compounded GLP-1s?

This page quotes the FDA, a court and sellers' own pages; it is not legal or medical advice. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.